Use of Azithromycin in COVID-19: A Cautionary Tale

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1007/s40261-020-00961-z

Use of Azithromycin in COVID-19: A Cautionary Tale

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine.

Original language	English
Pages (from-to)	989-990
Number of pages	2
Journal	Clinical Drug Investigation
Volume	40
Issue number	10
Early online date	20 Aug 2020
DOIs	https://doi.org/10.1007/s40261-020-00961-z
Publication status	Published - 1 Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40261-020-00961-zLicence: Unspecified

Cite this

@article{fcc7f65aa3b2442494fb73eff4d60844,

title = "Use of Azithromycin in COVID-19: A Cautionary Tale",

abstract = "The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine. ",

keywords = "COVID-19, Azithromycin",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s40261-020-00961-z",

language = "English",

volume = "40",

pages = "989--990",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis International Ltd",

number = "10",

}

TY - JOUR

T1 - Use of Azithromycin in COVID-19

T2 - A Cautionary Tale

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/10/1

Y1 - 2020/10/1

N2 - The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine.

AB - The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine.

KW - COVID-19

KW - Azithromycin

U2 - 10.1007/s40261-020-00961-z

DO - 10.1007/s40261-020-00961-z

M3 - Letter

C2 - 32816219

VL - 40

SP - 989

EP - 990

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 10

ER -

Use of Azithromycin in COVID-19: A Cautionary Tale

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this